financetom
FLR
financetom
/
Industrials
/
FLR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Fluor CorporationFLR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Fluor Corporation provides engineering, procurement, and construction (EPC); fabrication and modularization; operation and maintenance; asset integrity; and project management services worldwide.

It operates through four segments: Energy Solutions, Urban Solutions, Mission Solutions, and Other. The Energy Solutions segment provides solutions to the energy transition markets, including asset decarbonization, carbon capture, renewable fuels, waste-to-energy, green chemicals, hydrogen, nuclear power, and other low-carbon energy sources.

It also provides consulting services, including feasibility studies, process assessments, and project finance structuring; and a range of services for small modular reactor technologies, as well as operation support services for nuclear power facilities and managing waste.

This segment serves the oil, gas, and petrochemical industries. The Urban Solutions segment offers EPC and project management services to the infrastructure, advanced technologies, life sciences, and mining and metals industries.

This segment also provides staffing services to the company and third-party clients with technical, professional, and craft resources on a contract or permanent placement basis.

The Mission Solutions segment offers technical solutions to the U.S. and other governments. It also delivers solutions for nuclear security and operation, nuclear waste management, and laboratory management; and operation and maintenance, logistics, EPC, and life support solutions for mission-critical facilities across U.S. military service organizations.

This segment offers site management, environmental remediation, and decommissioning for nuclear remediation at governmental facilities, as well as services to commercial nuclear clients.

The Other segment researches, develops, licenses, and commercializes small modular reactor technology.

The company was founded in 1912 and is headquartered in Irving, Texas.

Latest News >
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Jul 11, 2024
The US Bureau of Labor Statistics (BLS) has published this months data for the Consumer Price Index. As is normally the case, this has caused some volatility within the cryptocurrency markets. In June, the CPI for all urban consumers fell 0.1%, seasonally adjusted This represents a change of 3% over the last 12 months, not seasonally adjusted. On the news,...
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
Jul 11, 2024
July 11 (Reuters) - PepsiCo ( PEP ) missed expectations for second-quarter revenue on Thursday as a series of price hikes and competition from private-label brands slowed sales of its snacks and soda mainly in the United States, its largest market. Analysts have said that product prices, which are starting to normalize almost after two years of multiple hikes, are...
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 11, 2024
July 11 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON STRENGTHENS PIPELINE TO LEAD IN ATOPIC DERMATITIS WITH THE COMPLETION OF THE ACQUISITION OF YELLOW JERSEY THERAPEUTICS, GAINING OWNERSHIP OF NM26 Source text for Eikon: Further company coverage: ...
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Jul 11, 2024
08:16 AM EDT, 07/11/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that it has regained full rights to commercialize Vafseo tablets in the US after agreeing to terminate a license agreement with CSL Vifor. Akebia said it is now allowed to deal directly with all dialysis organizations effective immediately. Akebia said CSL Vifor is entitled to quarterly...
Copyright 2023-2025 - www.financetom.com All Rights Reserved